• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌黄素单加氧酶EtaA以及人源FMO1和FMO3对氨硫脲的氧化激活作用。

Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3.

作者信息

Qian Lian, Ortiz de Montellano Paul R

机构信息

Department of Pharmaceutical Chemistry, University of California, 600 16th Street, San Francisco, California 94143-2280, USA.

出版信息

Chem Res Toxicol. 2006 Mar;19(3):443-9. doi: 10.1021/tx050328b.

DOI:10.1021/tx050328b
PMID:16544950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2533439/
Abstract

Thiacetazone (TAZ) and ethionamide (ETA) are, respectively, thiourea- and thioamide-containing second line antitubercular prodrugs for which there is an extensive clinical history of cross-resistance in Mycobacterium tuberculosis. EtaA, a recently identified flavin-containing monooxygenase (FMO), is responsible for the oxidative activation of ETA in M. tuberculosis. We report here that EtaA also oxidizes TAZ and identify a sulfinic acid and a carbodiimide as the isolable metabolites. Both of these metabolites are derived from an initial sulfenic acid intermediate. Oxidation of TAZ by EtaA at basic pH favors formation of the carbodiimide, whereas neutral or acidic conditions favor formation of the sulfinic acid. The same metabolites are formed from TAZ by human FMO1 and FMO3. The sulfenic acid and carbodiimide metabolites, but not the sulfinic acid product, readily react with glutathione, the first to regenerate the parent drug and the second to give a glutathione adduct. These reactions may contribute to the antitubercular activity and/or toxicity of TAZ.

摘要

硫乙酰胺(TAZ)和乙硫异烟胺(ETA)分别是含硫脲和硫代酰胺的二线抗结核前体药物,在结核分枝杆菌中存在广泛的交叉耐药临床历史。EtaA是最近鉴定出的一种含黄素单加氧酶(FMO),负责结核分枝杆菌中ETA的氧化激活。我们在此报告EtaA也能氧化TAZ,并鉴定出亚磺酸和碳二亚胺为可分离的代谢产物。这两种代谢产物均源自最初的亚磺酸中间体。在碱性pH条件下,EtaA对TAZ的氧化有利于碳二亚胺的形成,而中性或酸性条件则有利于亚磺酸的形成。人FMO1和FMO3对TAZ的氧化也会生成相同的代谢产物。亚磺酸和碳二亚胺代谢产物,而非亚磺酸产物,能与谷胱甘肽迅速反应,前者使母体药物再生,后者生成谷胱甘肽加合物。这些反应可能有助于TAZ的抗结核活性和/或毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/f18433c1ec04/nihms63264f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/375f98eff591/nihms63264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/f6b0c6e7f113/nihms63264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/a3769a002713/nihms63264f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/0081167432b9/nihms63264f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/62c4ed283399/nihms63264f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/3e7993f08d54/nihms63264f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/d1f5bccf0e76/nihms63264f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/104905f9e109/nihms63264f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/f18433c1ec04/nihms63264f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/375f98eff591/nihms63264f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/f6b0c6e7f113/nihms63264f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/a3769a002713/nihms63264f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/0081167432b9/nihms63264f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/62c4ed283399/nihms63264f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/3e7993f08d54/nihms63264f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/d1f5bccf0e76/nihms63264f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/104905f9e109/nihms63264f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed4/2533439/f18433c1ec04/nihms63264f9.jpg

相似文献

1
Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3.结核分枝杆菌黄素单加氧酶EtaA以及人源FMO1和FMO3对氨硫脲的氧化激活作用。
Chem Res Toxicol. 2006 Mar;19(3):443-9. doi: 10.1021/tx050328b.
2
Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide.人含黄素单加氧酶2.1催化抗结核药物氨硫脲和乙硫异烟胺的氧化反应。
Drug Metab Dispos. 2009 Jan;37(1):178-86. doi: 10.1124/dmd.108.024158. Epub 2008 Oct 23.
3
Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.抗结核药物乙硫异烟胺在小鼠和人类FMO1、FMO2和FMO3以及小鼠和人类肺微粒体中的代谢。
Toxicol Appl Pharmacol. 2008 Dec 15;233(3):420-7. doi: 10.1016/j.taap.2008.09.017. Epub 2008 Oct 1.
4
Further Insights into the Oxidative Pathway of Thiocarbonyl-Type Antitubercular Prodrugs: Ethionamide, Thioacetazone, and Isoxyl.进一步深入了解硫羰型抗结核前药的氧化途径:乙硫异烟胺、硫代乙酰胺和异烟腙。
Chem Res Toxicol. 2021 Aug 16;34(8):1879-1889. doi: 10.1021/acs.chemrestox.1c00164. Epub 2021 Jul 28.
5
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis.耐多药结核分枝杆菌中乙硫异烟胺的激活与敏感性
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9677-82. doi: 10.1073/pnas.97.17.9677.
6
Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases.细菌和哺乳动物黄素单加氧酶对抗结核硫代酰胺和硫脲前药的生物活化作用。
Chem Biol Interact. 2011 Jun 30;192(1-2):21-5. doi: 10.1016/j.cbi.2010.09.015. Epub 2010 Sep 21.
7
The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase.抗结核药物乙硫异烟胺由一种黄素蛋白单加氧酶激活。
J Biol Chem. 2002 Apr 12;277(15):12824-9. doi: 10.1074/jbc.M110751200. Epub 2002 Jan 31.
8
The prodrug activator EtaA from Mycobacterium tuberculosis is a Baeyer-Villiger monooxygenase.来自结核分枝杆菌的前药激活剂EtaA是一种拜耳-维利格单加氧酶。
J Biol Chem. 2004 Jan 30;279(5):3354-60. doi: 10.1074/jbc.M307770200. Epub 2003 Nov 10.
9
Xanthates: Metabolism by Flavoprotein-Containing Monooxygenases and Antimycobacterial Activity.黄原酸盐:含黄素蛋白单加氧酶代谢与抗分枝杆菌活性。
Drug Metab Dispos. 2018 Aug;46(8):1091-1095. doi: 10.1124/dmd.118.081984. Epub 2018 May 18.
10
Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites.乙硫异烟胺的仿生活化及其转化为活性和非活性代谢物的前所未有的机制。
Org Biomol Chem. 2016 Sep 21;14(37):8848-8858. doi: 10.1039/c6ob01561a.

引用本文的文献

1
Pulmonary Infections: Therapeutic Obstacles and Progress in Drug Development.肺部感染:治疗障碍与药物研发进展
Pharmaceuticals (Basel). 2025 Jun 13;18(6):891. doi: 10.3390/ph18060891.
2
Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and spp.噻唑、缩氨基硫脲和氨基脲衍生物作为抗锥虫和其他物种抗寄生虫剂的最新进展
Molecules. 2025 Apr 16;30(8):1788. doi: 10.3390/molecules30081788.
3
Genetic and Cheminformatic Characterization of Inhibitors Discovered in the Molecular Libraries Small Molecule Repository.分子文库小分子储存库中发现的抑制剂的遗传和化学信息学特征分析
ACS Infect Dis. 2025 Apr 11;11(4):882-893. doi: 10.1021/acsinfecdis.4c00936. Epub 2025 Mar 25.
4
Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.近期抗结核药物的生物化学进展:挑战与未来。
Curr Top Med Chem. 2024;24(21):1829-1855. doi: 10.2174/0115680266286294240610102911.
5
Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.药物在人药物代谢酶催化反应中形成潜在毒性代谢物。
Arch Toxicol. 2024 Jun;98(6):1581-1628. doi: 10.1007/s00204-024-03710-9. Epub 2024 Mar 23.
6
NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs and .NSC19723,一种类似噻唑酮的苯甲醛缩氨硫脲,可提高抗结核药物的疗效。
Microbiol Spectr. 2022 Dec 21;10(6):e0259222. doi: 10.1128/spectrum.02592-22. Epub 2022 Oct 31.
7
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.选定的非 P450 人氧化还原酶在化学品的保护和毒性作用中的作用:反应的综述和汇编。
Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1.
8
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in .一种噻唑烷酮的香豆素类似物作为 HadA 的双重共价抑制剂和潜在荧光标记物。
ACS Infect Dis. 2021 Mar 12;7(3):552-565. doi: 10.1021/acsinfecdis.0c00325. Epub 2021 Feb 22.
9
Xanthates: Metabolism by Flavoprotein-Containing Monooxygenases and Antimycobacterial Activity.黄原酸盐:含黄素蛋白单加氧酶代谢与抗分枝杆菌活性。
Drug Metab Dispos. 2018 Aug;46(8):1091-1095. doi: 10.1124/dmd.118.081984. Epub 2018 May 18.
10
EthA/R-Independent Killing of by Ethionamide.乙硫异烟胺对EthA/R的非依赖性杀伤作用
Front Microbiol. 2017 Apr 25;8:710. doi: 10.3389/fmicb.2017.00710. eCollection 2017.

本文引用的文献

1
Treatment of tuberculosis: present status and future prospects.结核病的治疗:现状与未来展望。
Bull World Health Organ. 2005 Nov;83(11):857-65. Epub 2005 Nov 10.
2
Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG.结核分枝杆菌KatG中异烟肼耐药性与超氧化物反应性之间的相关性。
J Am Chem Soc. 2005 Sep 28;127(38):13428-42. doi: 10.1021/ja054366t.
3
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.哺乳动物含黄素单加氧酶:结构/功能、基因多态性及其在药物代谢中的作用。
Pharmacol Ther. 2005 Jun;106(3):357-87. doi: 10.1016/j.pharmthera.2005.01.001.
4
[Multiple drug resistance: a threat for tuberculosis control].[多重耐药:对结核病控制的一种威胁]
Rev Panam Salud Publica. 2004 Jul;16(1):68-73. doi: 10.1590/s1020-49892004000700013.
5
A century of tuberculosis.
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1181-6. doi: 10.1164/rccm.200402-140OE.
6
Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione.人源含黄素单加氧酶2的S-氧化作用:硫脲形成亚磺酸及谷胱甘肽的氧化
Chem Res Toxicol. 2004 May;17(5):633-40. doi: 10.1021/tx034253s.
7
Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.N-取代的N'-(4-咪唑基乙基)硫脲在精密切割大鼠肝切片中的细胞毒性比较
Toxicology. 2004 Apr 15;197(2):81-91. doi: 10.1016/j.tox.2003.11.014.
8
Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman.巯基乙醇对结核分枝杆菌埃尔德曼菌株的生长至关重要。
J Bacteriol. 2003 Nov;185(22):6736-40. doi: 10.1128/JB.185.22.6736-6740.2003.
9
The global situation of MDR-TB.耐多药结核病的全球形势。
Tuberculosis (Edinb). 2003;83(1-3):44-51. doi: 10.1016/s1472-9792(02)00058-6.
10
Mycothiol biochemistry.麦角硫因生物化学
Arch Microbiol. 2002 Dec;178(6):388-94. doi: 10.1007/s00203-002-0469-4. Epub 2002 Sep 3.